Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jun 04, 2020 | Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 18,574 | -- | 18,574 | |
| Jun 04, 2020 | Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 5,855 | -- | 21,000 | |
| Jun 04, 2020 | Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 18,574 | -- | 18,574 | |
| Jun 04, 2020 | Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 5,855 | -- | 33,933 | |
| Jun 04, 2020 | Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 18,574 | -- | 18,574 | |
| Jun 04, 2020 | Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 5,855 | -- | 21,000 | |
| Jun 04, 2020 | Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 18,574 | -- | 18,574 | |
| Jun 04, 2020 | Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 5,855 | -- | 29,467 | |
| Jun 04, 2020 | Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | Form 4 | 18,574 | -- | 18,574 | |
| Jun 15, 2020 | Chief Medical Officer | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 1,846 | $11.14 | 165,108 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.